181 related articles for article (PubMed ID: 34983118)
1. Evaluating the efficacy of secondary transurethral resection of the bladder for high-grade Ta tumors.
Lee K; Jeong SH; Yoo SH; Ku JH
Investig Clin Urol; 2022 Jan; 63(1):14-20. PubMed ID: 34983118
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients?
Soria F; D'Andrea D; Moschini M; Giordano A; Mazzoli S; Pizzuto G; Hurle R; Colombo R; Briganti A; Altieri V; Shariat SF; Gontero P
Urol Oncol; 2020 Mar; 38(3):77.e1-77.e7. PubMed ID: 31526650
[TBL] [Abstract][Full Text] [Related]
3. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens.
Cheng L; Neumann RM; Weaver AL; Cheville JC; Leibovich BC; Ramnani DM; Scherer BG; Nehra A; Zincke H; Bostwick DG
Am J Clin Pathol; 2000 Feb; 113(2):275-9. PubMed ID: 10664630
[TBL] [Abstract][Full Text] [Related]
4. Clinical determinants of recurrence in pTa bladder cancer following transurethral resection of bladder tumor.
Jeong SH; Han JH; Jeong CW; Kim HH; Kwak C; Yuk HD; Ku JH
BMC Cancer; 2022 Jun; 22(1):631. PubMed ID: 35676678
[TBL] [Abstract][Full Text] [Related]
5. [T1 high-grade bladder cancer - value of second operation with prognostuic parameters of first operation: analysis of 167 cases].
Lazica DA; Böttcher S; Degener S; von Rundstedt FC; Brandt AS; Roth S; Störkel S; Mathers MJ
Aktuelle Urol; 2013 Mar; 44(2):124-8. PubMed ID: 23580383
[TBL] [Abstract][Full Text] [Related]
6. Narrow-band imaging (NBI) and white light (WLI) transurethral resection of the bladder in the treatment of non-muscle-invasive bladder cancer.
Montanari E; de la Rosette J; Longo F; Del Nero A; Laguna P
Arch Ital Urol Androl; 2012 Dec; 84(4):179-83. PubMed ID: 23427740
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study.
Hermann GG; Mogensen K; Carlsson S; Marcussen N; Duun S
BJU Int; 2011 Oct; 108(8 Pt 2):E297-303. PubMed ID: 21414125
[TBL] [Abstract][Full Text] [Related]
8. Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette-Guerin.
Calò B; Falagario U; Sanguedolce F; Veccia A; Chirico M; Carvalho-Diaz E; Mota P; Lima E; Autorino R; Carrieri G; Cormio L
World J Urol; 2020 Dec; 38(12):3161-3167. PubMed ID: 32062805
[TBL] [Abstract][Full Text] [Related]
9. Second-look TURBT: evaluation of anatomopatological and oncologic results in a single center.
Maltagliati M; Varca V; Milandri R; Micali S; Bocchialini T; Rocco BMC; Gregori A
Acta Biomed; 2020 May; 91(2):322-325. PubMed ID: 32420968
[TBL] [Abstract][Full Text] [Related]
10. Narrow Band Imaging reduces persistence of cancer in patients with pT1 high grade bladder cancer.
Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Mavilla L; Tariciotti P; Rizzo G; Fabi F; Falavolti C; Aloisi P; Vincenti G; Tema G; Lombardo R
Eur J Surg Oncol; 2019 Mar; 45(3):466-470. PubMed ID: 30041940
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer.
Sauer R; Birkenhake S; Kühn R; Wittekind C; Schrott KM; Martus P
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):121-7. PubMed ID: 9422567
[TBL] [Abstract][Full Text] [Related]
12. The need for re-TUR of the bladder in non-muscle invasive bladder cancer: risk factors of tumor persistence in re-TUR specimens.
Husillos Alonso A; Rodríguez Fernández E; Herranz Amo F; López López E; Aragón Chamizo J; Ramírez Martínez D; Durán Merino R; Hernández Fernández C
Minerva Urol Nefrol; 2014 Dec; 66(4):233-40. PubMed ID: 25531192
[TBL] [Abstract][Full Text] [Related]
13. The clinical significance of a second transurethral resection for T1 high-grade bladder cancer: Results of a prospective study.
Shim JS; Choi H; Noh TI; Tae JH; Yoon SG; Kang SH; Bae JH; Park HS; Park JY
Korean J Urol; 2015 Jun; 56(6):429-34. PubMed ID: 26078839
[TBL] [Abstract][Full Text] [Related]
14. Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor.
Ferro M; Katalin MO; Buonerba C; Marian R; Cantiello F; Musi G; Di Stasi S; Hurle R; Guazzoni G; Busetto GM; Del Giudice F; Perdonà S; Del Prete P; Mirone V; Borghesi M; Porreca A; Artibani W; Bove P; Lima E; Autorino R; Crisan N; Abu Farhan AR; Battaglia M; Ditonno P; Serretta V; Russo GI; Terracciano D; di Lorenzo G; Damiano R; Sonpavde G; Vartolomei MD; de Cobelli O; Lucarelli G
Urol Oncol; 2020 May; 38(5):459-464. PubMed ID: 32173242
[TBL] [Abstract][Full Text] [Related]
15. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
16. Second transurethral resection after Ta high-grade bladder tumor: a 4.5-year period at a single university center.
Lazica DA; Roth S; Brandt AS; Böttcher S; Mathers MJ; Ubrig B
Urol Int; 2014; 92(2):131-5. PubMed ID: 23988813
[TBL] [Abstract][Full Text] [Related]
17. Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer.
Blute ML; Rushmer TJ; Shi F; Fuller BJ; Abel EJ; Jarrard DF; Downs TM
J Urol; 2015 Nov; 194(5):1214-9. PubMed ID: 26173101
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
19. Positive urine cytology and carcinoma in situ prior to second transurethral resection of the bladder correlate with positive second resection histology and the need for subsequent cystectomy.
Lodde M; Mayr R; Martini T; Comploj E; Palermo S; Trenti E; Hanspeter E; Fritsche HM; Mian C; Pycha A
World J Urol; 2012 Dec; 30(6):841-6. PubMed ID: 23143733
[TBL] [Abstract][Full Text] [Related]
20. Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free Survival.
Mastroianni R; Brassetti A; Krajewski W; Zdrojowy R; Salhi YA; Anceschi U; Bove AM; Carbone A; De Nunzio C; Fuschi A; Ferriero M; Nacchia A; Pastore AL; Tema G; Tuderti G; Gallucci M; Simone G
Eur Urol Focus; 2021 Nov; 7(6):1324-1331. PubMed ID: 32900676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
